SOUFFLÉ THERAPEUTICS™ ANNOUNCES OVERSUBSCRIBED $135 MILLION SERIES B FINANCING TO ADVANCE LEAD CLINICAL PROGRAMS AND CONTINUED PIPELINE PROGRESS

Reuters · 2d ago

Please log in to view news